Literature DB >> 265177

Ph1-positive childhood leukemias: spectrum of lymphoid-myeloid expressions.

E N Forman, T Padre-Mendoza, P S Smith, B E Barker, P Farnes.   

Abstract

Two children presented with Ph1-positive leukemia, confirmed by Giemsa banding as 22q-. One child showed an initial presentation characteristic of acute lymphoblastic leukemia, followed by development of chronic myelocytic leukemia 2 yr later. A second child presented in blast crisis. Both patients showed blast cells possessing both lymphoid and myeloid characteristics, as demonstrated by histochemical, biochemical, or surface receptor properties of each cell series. The evidence provided supports the assumption of mixed lymphoid-myeloid properties of blast cells in chronic myelocytic leukemia in children. Detailed study of the leukemic cells may aid in the understanding of complex stem cell relationships and suggest more effective therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 265177

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  6 in total

Review 1.  Genetics of neoplasia--impact of ecogenetics on oncogenesis. A review.

Authors:  D T Purtilo; L Paquin; T Gindhart
Journal:  Am J Pathol       Date:  1978-06       Impact factor: 4.307

2.  Chronic myelocytic leukemia. Origin of some lymphocytes from leukemic stem cells.

Authors:  P J Fialkow; A M Denman; R J Jacobson; M N Lowenthal
Journal:  J Clin Invest       Date:  1978-10       Impact factor: 14.808

3.  A nine-year cytogenetic follow-up of a patient injected with Thorotrast.

Authors:  T Ishihara; S Kohno; I Hayata; T Kumatori
Journal:  Hum Genet       Date:  1978-05-16       Impact factor: 4.132

4.  Translocations (4p+; 6q-) and (12q-; Xp+) in blastic phase of a Ph1-positive chronic myeloid leukemia.

Authors:  S Suciu; E Marinca; F Bornuz; M Crisan; L Petrov; E Rădulescu
Journal:  Blut       Date:  1984-10

5.  New complex Ph' translocation t (10; 14; 22) in bone marrow cells and in PHA-stimulated peripheral blood cultures in chronic myelocytic leukaemia.

Authors:  F Shabtai; U Gafter; S Weiss; M Djaldetti; I Halbrecht
Journal:  J Cancer Res Clin Oncol       Date:  1980       Impact factor: 4.553

6.  Fluorescence polarization with FDA in leukaemic cells: a clear difference between myelogenous and lymphocytic origins.

Authors:  H Tsuda; H Maeda; S Kishimoto
Journal:  Br J Cancer       Date:  1981-06       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.